Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021

Background This study elucidates recent trends in application and match rates in the Cardiovascular Disease Fellowship Match. We hypothesized that (1) match rates have increased with time; (2) match rates are highest for US allopathic graduates; and (3) most candidates match at 1 of their top 3 rank...

Full description

Bibliographic Details
Main Authors: Jason Silvestre, Ahmed Brgdar, Horace M. DeLisser
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.028237
_version_ 1827746372537810944
author Jason Silvestre
Ahmed Brgdar
Horace M. DeLisser
author_facet Jason Silvestre
Ahmed Brgdar
Horace M. DeLisser
author_sort Jason Silvestre
collection DOAJ
description Background This study elucidates recent trends in application and match rates in the Cardiovascular Disease Fellowship Match. We hypothesized that (1) match rates have increased with time; (2) match rates are highest for US allopathic graduates; and (3) most candidates match at 1 of their top 3 ranked fellowship choices. Methods and Results This was a retrospective cohort study of all applicants in the Cardiovascular Disease Fellowship Match from 2010 to 2021 (n=14 674). Chi‐square tests were used to compare trends over time and match rates by applicant archetype (US allopathic graduates and non‐US allopathic graduates). The annual number of applicants increased from 1184 to 1575 (33% increase) while training positions increased 718 to 1045 (46% increase) over the study period. The percentage of applicants that matched increased from 61% in 2010 to 66% in 2021 (P=0.090). The average match rate was 70% over the study period. During each year, US allopathic graduates had higher match rates than non‐US allopathic graduates (P<0.001), but this disparity narrowed with time (83% versus 41% in 2010 and 83% versus 54% in 2021). Most applicants matched at 1 of their top 3 choices (first, 37%; second, 12%; third, 7%). Applicants matching at 1 of their top 3 choices decreased from 51% in 2010 to 48% in 2021 (P=0.704). Conclusions The Cardiovascular Disease Fellowship Match has remained equally competitive over the past decade. US allopathic graduates have an advantage over non‐US allopathic graduates. Most applicants match at 1 of their top 3 ranked fellowship choices.
first_indexed 2024-03-11T05:21:29Z
format Article
id doaj.art-052e294639294c7f9cbdc0e70755d6db
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-03-11T05:21:29Z
publishDate 2022-12-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-052e294639294c7f9cbdc0e70755d6db2023-11-17T17:47:34ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802022-12-01112410.1161/JAHA.122.028237Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021Jason Silvestre0Ahmed Brgdar1Horace M. DeLisser2Perelman School of Medicine Philadelphia PAHoward University College of Medicine Washington DCPerelman School of Medicine Philadelphia PABackground This study elucidates recent trends in application and match rates in the Cardiovascular Disease Fellowship Match. We hypothesized that (1) match rates have increased with time; (2) match rates are highest for US allopathic graduates; and (3) most candidates match at 1 of their top 3 ranked fellowship choices. Methods and Results This was a retrospective cohort study of all applicants in the Cardiovascular Disease Fellowship Match from 2010 to 2021 (n=14 674). Chi‐square tests were used to compare trends over time and match rates by applicant archetype (US allopathic graduates and non‐US allopathic graduates). The annual number of applicants increased from 1184 to 1575 (33% increase) while training positions increased 718 to 1045 (46% increase) over the study period. The percentage of applicants that matched increased from 61% in 2010 to 66% in 2021 (P=0.090). The average match rate was 70% over the study period. During each year, US allopathic graduates had higher match rates than non‐US allopathic graduates (P<0.001), but this disparity narrowed with time (83% versus 41% in 2010 and 83% versus 54% in 2021). Most applicants matched at 1 of their top 3 choices (first, 37%; second, 12%; third, 7%). Applicants matching at 1 of their top 3 choices decreased from 51% in 2010 to 48% in 2021 (P=0.704). Conclusions The Cardiovascular Disease Fellowship Match has remained equally competitive over the past decade. US allopathic graduates have an advantage over non‐US allopathic graduates. Most applicants match at 1 of their top 3 ranked fellowship choices.https://www.ahajournals.org/doi/10.1161/JAHA.122.028237ACGMEcardiologycardiovascularfellowshipmatchtraining
spellingShingle Jason Silvestre
Ahmed Brgdar
Horace M. DeLisser
Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
ACGME
cardiology
cardiovascular
fellowship
match
training
title Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021
title_full Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021
title_fullStr Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021
title_full_unstemmed Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021
title_short Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021
title_sort match outcomes for cardiovascular disease fellowship training 2010 to 2021
topic ACGME
cardiology
cardiovascular
fellowship
match
training
url https://www.ahajournals.org/doi/10.1161/JAHA.122.028237
work_keys_str_mv AT jasonsilvestre matchoutcomesforcardiovasculardiseasefellowshiptraining2010to2021
AT ahmedbrgdar matchoutcomesforcardiovasculardiseasefellowshiptraining2010to2021
AT horacemdelisser matchoutcomesforcardiovasculardiseasefellowshiptraining2010to2021